Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, August 26, 2019

OUHSC researchers, you may find this press release of interest:

The release describes the federal charges filed this week against a faculty researcher at the University of Kansas. 

The researcher neglected to disclose his appointments at other institutions on his federal grant applications, as

required by the granting agencies, and to the university, as required by the KU conflicts of interest policy. 

Disclosures of  potential conflicts of interest, such as support from or appointments at other institutions, are required

by federal funding agencies (see, for example,

and by OU’s Conflicts of Interest policy. 

The linked documents are good reminders to all researchers who receive federal funds to ensure their disclosures of

potential conflicts of interest are complete and accurate for each grant submission and renewal.  I strongly encourage

you to review the grant applications you have submitted for your current grants and ensure you have fully disclosed

any conflicts, including appointments at other institutions – both U.S. and foreign – to the granting agency and to the

University.  If you have questions about reporting conflicts to the University, please contact Martha Ogilvie at For assistance with grants, please contact your Sponsored Program Administrator in the

Office of Research Administration at



IMPORTANT NIH INFORMATION:  ORCID Number – an ORCID Number is required of all Individuals Supported

by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020.  This

requirement will go into effect October 1, 2020. For the specific Notice and instructions on how to get your assigned

ORCID Number please go to:



The University of Oklahoma Center on Native Health Center of Biomedical Research Excellence (COBRE) on the

Norman campus  is  requesting preproposals to advance inquiry into the social and behavioral determinants of the

health of American Indian people in Oklahoma. Interested candidates should submit a one-page overview (including

specific aims) of their proposed research as a PDF file to Paul Spicer ( no later than September 15,

2019. Project budgets generally will not exceed $150,000 in direct costs for each year. 

For additional information refer to the attached document. Call for Proposals 190821.docx?ver=2019-08-26-082925-747


Save the Date – ORA Noon Conference

Navigating the ORA Proposal Submission Process

Speaker(s):      Caitlin Novotny, MBA, CRA, Sponsored Programs Administrator II, Office of Research Administration

Offered:             September 25, 2019  LIB-299 12-1pm

Overview:          This session will cover the basics of proposal preparation and map out the process of submission through

the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for during the

pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies. We will also

cover topics related to proposal submission, such as grant routing forms and the systems used to submit federal grants.

The overall goal of this presentation is to provide a basic understanding of and advice on proposal preparation and submission.



National Cancer Institute Predoctoral to Post-Doctoral Fellow Transition Award (F99/K00)

OUHSC can nominate one graduate student in their 3rd or 4th year since beginning graduate school who is working

towards their PhD degree to apply for an F99/K00 award from the NCI


Note: Dual-degree, or professional doctorate/clinical degree students are not eligible.

  1. Purpose:  The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to

encourage and retain outstanding graduate students recognized by their institutions for their high potential and

strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition

of talented graduate students into successful cancer research postdoctoral appointments, and provide

opportunities for career development activities relevant to their long-term career goals of becoming independent

cancer researchers. Final F99/K00 application due date at NIH is December 4th.

  1. Eligibility:  3rd or 4th year graduate student working on a specific cancer-related Ph.D. dissertation project that

wants to transition in the next 1-2 years to a postdoctoral fellowship research in cancer research.

  1. Submitting a pre-proposal:  A pre-proposal must be submitted to the Graduate College by September 6, 2019.

Pre-proposals must include:

  1. Specific Aims Page: there are 2 required Specific Aims as follow:
  1. Aim 1: The Dissertation Research Project
  2. Aim 2: The Postdoctoral Research Direction
  1. Letter of support from F99 sponsor(s)
  2. Full CV of applicant including academic record and prior research experience
  3. NIH Biosketch of sponsor(s)
  1. Submit the pre-proposal as a single file in PDF format to: in the Graduate College
  2. Pre-proposals will be reviewed by a panel of expert cancer researchers and educators.
  3. Questions: contact or



NIH Contract SBIR Solicitation

NIH has SBIR funding for health related startup or small business (e.g. pharma, health IT, medical devices, diagnostics, mobile

health, etc) ( This is not the normal NIH “grant” SBIR – it

comes out once a year and is the best chance anyone has to secure NIH SBIR funding. A key difference with the NIH Contract

SBIR opportunity is that you must respond to a specific topic – and there is no guarantee these topics will be back next year

(see attached).  The Oklahoma Catalyst Program can assist if you are interested in applying:



The Office of Technology Development will offer the Innovation to Impact Series Session 1“Patents 101: First Do No

Harm – How to Write and Speak About Your Invention Without Losing US or Foreign Patent Rights.” Learn

what is a patent; How/why does a public disclosure affect patentability; Types of public disclosures; How to publish without

hurting your patent rights; and Key milestones of the patent process. Chris Corbett, Director of Intellectual Property, will be

presenting.  This session will occur on August 28th  from Noon- 1:00 pm in Biomedical Research Center Building,  Room 103.

Lunch will be provided.  Please RSVP to by August 22nd. Space is limited to the first 15 attendees.



DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to support

collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of biomedical engineering

Deadline September 6, 2019 – please see guidelines and face page attached. page_final.pdf?ver=2019-07-01-074315-193


OSCTR TPIR Trainee Program

Seeking applicants for the sixth year of the research training program Translating Practice into

Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic

Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal

of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to

translate their clinical observations and ideas for improving practice into practical and feasible research

projects. Attached is a detailed description and application due September 3, 2019. TPIR information 2019.pdf?ver=2019-08-12-083211-813


Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm

Diabetes Center Research Symposium.  This event will be held on Friday, November 15, 2019 at the Samis Education

Center at Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced later this summer.  Additional

details will be posted on  Questions?  Please email





Notice of Information: NIAAA Preclinical Medication Efficacy Testing Program (NOT-AA-19-021)


NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-017, "Cardiovascular Developmental

Biology Data Resource Center (U01 - Clinical Trial Not Allowed)" (NOT-HL-19-716)


NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-015, "Pediatric Cardiac Genomics

Consortium (U01 - Clinical Trial Not Allowed)" (NOT-HL-19-717)


Notice of Correction to the Companion Program Announcement Cited in PA-19-118, Mentored Patient-Oriented

Research Career Development Award (Parent K23 Independent Clinical Trial Required)


Notice of Change to Other Attachments in RFA-AI-19-045 "HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)"



Notice to Extend PAR-18-113, Center of Excellence for Research on Complementary and Integrative Health

(P01, Clinical Trial Optional) (NOT-AT-19-032)


Notice of NCCIH's Withdrawal from Participation in PAR-18-494, "Device-Based Treatments for Substance Use

Disorders (UG3/UH3, Clinical Trial Optional)" (NOT-AT-19-033)


Notice of Expiration for RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"


Notice of Intent to Publish Reissuance of RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"


Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimers Disease


Notice of Special Interest (NOSI): Public Health Research on Cannabis (NOT-DA-19-065)


Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health

(Parent R01 Clinical Trial Not Allowed) (NOT-HL-19-712)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

(R21 Clinical Trial Optional) (PAR-19-339) – Deadline October 9, 2019 and June 10, 2020


Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

(R01 Clinical Trial Optional) (PAR-19-340) – Deadline October 9, 2019


Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused

Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
(PAR-19-342) - Deadline November 15, 2019 and November 2, 2020


Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career

Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed) (PAR-19-343)
Deadline February 12, 2020


Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior

(R01 Clinical Trial Optional) (PAR-19-344) – Deadline March10, 2020


NIDA Program Project Grant Applications (P01 Clinical Trial Optional) (PAR-19-345) – Deadline September 25, 2019


Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

(PAR-19-346) – Deadline October 16, 2019.


Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

(PAR-19-347) - Deadline October 16, 2019.


Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem

(R01 Clinical Trial Optional) (PAR-19-348) - Deadline October 9, 2019 and June 10, 2020


NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) (PAR-19-349) – Deadline November 6, 2019


Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

(PAR-19-350) – Deadline October 9, 2019 and June 10, 2020


Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences

(R25 Clinical Trial Not Allowed) (RFA-AG-20-031) – Deadline January 21, 2020


Hazardous Materials Worker Health and Safety Training (U45 Clinical Trial Not Allowed) (RFA-ES-19-003)
Deadline November 21, 2019


HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed) (RFA-ES-19-004)
Deadline November 21, 2019


Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)

(RFA-HL-20-030) - Deadline October 18, 2019